311 Phase II trial of lymphodepletion plus adoptive cell transfer with or without dendritic cell vaccination in patients with metastatic melanoma

• Michael Davies,
• Michael Wong,
• Sapna Patel,
• Cassian Yee,
• Adi Diab,
• Patrick Hwu,
• Cara Haymaker,
• Chantale Bernatchez,
• Rodabe Amaria,
• Hussein Tawbi,
• Isabella Glitza,
• Roland Bassett,
• Chantal Saberian,
• Marie Andree Forget,
• Gregory Lizee,
• Jeniffer McQuade

Affiliations

Michael Davies

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Michael Wong

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Sapna Patel

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Cassian Yee

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Adi Diab

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Patrick Hwu

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Cara Haymaker

1The University of Texas MD Anderson Cancer Center, Bellaire, TX, USA

Chantale Bernatchez

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Rodabe Amaria

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Hussein Tawbi

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Isabella Glitza

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Roland Bassett

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Chantal Saberian

1The University of Texas MD Anderson Cancer Center, Bellaire, TX, USA

Marie Andree Forget

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Gregory Lizee

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Jeniffer McQuade

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA